Cargando…

Application of Anti-Inflammatory Agents in Prostate Cancer

Chronic inflammation is a major cause of human cancers. The environmental factors, such as microbiome, dietary components, and obesity, provoke chronic inflammation in the prostate, which promotes cancer development and progression. Crosstalk between immune cells and cancer cells enhances the secret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatano, Koji, Fujita, Kazutoshi, Nonomura, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464558/ https://www.ncbi.nlm.nih.gov/pubmed/32824865 http://dx.doi.org/10.3390/jcm9082680

Ejemplares similares

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
por: Hayashi, Takuji, et al.
Publicado: (2019)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
por: Fujita, Kazutoshi, et al.
Publicado: (2023)

Emerging Relationship between the Gut Microbiome and Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2023)

Genomic Profiling of Prostate Cancer: An Updated Review
por: Hatano, Koji, et al.
Publicado: (2022)

Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Influence of Diet and Nutrition on Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2020)

Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review
por: Hatano, Koji, et al.
Publicado: (2023)

Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis
por: Matsushita, Makoto, et al.
Publicado: (2022)

Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Fucosylation in Urological Cancers
por: Fujita, Kazutoshi, et al.
Publicado: (2021)

Mutational Landscape and Environmental Effects in Bladder Cancer
por: Hayashi, Takuji, et al.
Publicado: (2020)

Extracellular vesicles in prostate cancer: a narrative review
por: Hatano, Koji, et al.
Publicado: (2021)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells
por: Hatano, Koji, et al.
Publicado: (2012)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Localization and potential role of prostate microbiota
por: Okada, Koichi, et al.
Publicado: (2022)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer
por: Li, Xin, et al.
Publicado: (2021)

EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
por: Sato, Mototaka, et al.
Publicado: (2013)

A novel model to predict positive prostate biopsy based on serum androgen level
por: Ujike, Takeshi, et al.
Publicado: (2017)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021)

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
por: Hayashi, Takuji, et al.
Publicado: (2016)

Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
por: Kato, Taigo, et al.
Publicado: (2023)

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
por: Koh, Yoko, et al.
Publicado: (2020)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
por: Maegawa, Yoko, et al.
Publicado: (2020)

Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2022)

Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2016)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
por: Yoshioka, Fumie, et al.
Publicado: (2023)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report
por: Yamamoto, Tetsuya, et al.
Publicado: (2021)

Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on (18)F–Prostate-Specific Membrane Antigen–1007 PET/CT
por: Soeda, Fumihiko, et al.
Publicado: (2021)

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
por: Nagahara, Akira, et al.
Publicado: (2015)

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution
por: Ujike, Takeshi, et al.
Publicado: (2016)

Correction to: Primary adrenal lymphoma: three case reports and review of Japanese cases
por: Nakazawa, Shigeaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_849fp6jqvbq2poponc6e0ftpdu